z-logo
open-access-imgOpen Access
Risk of Nephrogenic Systemic Fibrosis in Stage 4 and 5 Chronic Kidney Disease Following Group II Gadolinium-based Contrast Agent Administration: Subanalysis by Chronic Kidney Disease Stage
Author(s) -
Prasad R. Shankar,
Matthew S. Davenport
Publication year - 2020
Publication title -
radiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.118
H-Index - 295
eISSN - 1527-1315
pISSN - 0033-8419
DOI - 10.1148/radiol.2020201492
Subject(s) - medicine , nephrogenic systemic fibrosis , kidney disease , gadolinium , stage (stratigraphy) , fibrosis , kidney , disease , pathology , paleontology , materials science , metallurgy , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom